Research programme: anti-factor VIII antibody inhibitors - Genmab/Prothya BioSolutions
Alternative Names: Anti-factor VIII antibody inhibitors - Genmab/Prothya BioSolutionsLatest Information Update: 18 Mar 2022
At a glance
- Originator Sanquin Blood Supply Foundation
- Class
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Haemophilia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Haemophilia in Netherlands
- 23 Dec 2003 Preclinical trials in Haemophilia in Netherlands (unspecified route)